Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
4
×
boston blog main
boston top stories
clinical trials
life sciences
national blog main
fda
480 biomedical
ally bridge group
arsenal medical
big data analytics
biotech ipos
blackrock
bob langer
cancer
casdin capital
chronic rhinosinusitis
codiak biosciences
covid-19
cutaneous t-cell lymphoma
deals
diabetic nephropathy
drug delivery
dyne therapeutics
eventide asset management
exosome
focal segmental glomerulosclerosis
genzyme
george whitesides
goldfinch bio
inflammation
investing
ipo
irving investors
jay ghosh
jazz pharmaceuticals
keros therapeutics
lyra therapeutics
medical device
What
ipo
4
×
million
4
×
company
medicines
new
raised
biotech
brings
developing
drug
genetic
raises
tests
therapeutics
analysis
based
begin
bio
biosciences
bio’s
bring
bubbles
cells
class
clinical
codiak
debut
develop
diseases
disorders
dyne
dyne’s
employing
exosome
exosomes
formed
fund
goldfinch
kidney
late
Language
unset
Current search:
ipo
×
million
×
boston
×
@xconomy.com
3 years ago
Codiak Bio’s IPO Brings In $82M as Exosome Clinical Trials Begin
@xconomy.com
4 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
4 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses